References
- Biro G. P., Blais P. Perfluorocarbon blood substitutes. C.R.C. Crit. Rev. Oncol/Hematol 1987; 6: 311–374
- Biro G. P. Perfluorocarbon-based red cell-substitutes. (In Press) Transf. Med. Rev April, 1993
- Riess J. G., Dalfors J. L., Hanna G. K., Klein D. H., Krafft M-P., Pelura T. J., Schutt E. G. Development of highly fluid, concentrated and stable fluorocarbon emulsions for diagnosis and therapy. Biomat., Art. Cells and Immob. Biotech 1992; 20: 839–842
- Bartrum R. J., Jr., Berkowitz D. M., Hollenberg N. K. A simple radioactive microsphere method for measuring regional blood flow and cardiac output. Invest. Radiol 1974; 9: 126–132
- Mattrey R. F. Perfluorooctylbromide: a new contrast agent for CT, sonography and MR imaging. Amer. J. Radiol 1989; 152: 247–252
- Coley B. D., Mattrey R. F., Mitten R. M. The physiologic basis of the radiodense renal medulla after the administration of blood pool contrast agent PFOB. Invest. Radiol 1990; 25: 1287–1293
- Mattrey R. F., Hilpert P. L.C., Long D. Hemodynamic effects of intravenous lecithin-based perfluorocarbon emulsions in dogs. Crit. Care Med 1989; 17: 652–656
- Peck W. W., Mattrey R. F., Slutskyetal R. A. Perfluorooctyl bromide: acute hemodynamic effects, in pigs, of intravenous administration compared with the standard ionic contrast media. Invest. Radiol 1984; 19: 129–132
- Millard R. F., Baig H., Vatner S. F. Cardiovascular effects of radioactive microsphere suspensions and Tween 80 solutions. Amer. J. Physiol 1977; 232: H331–H334
- Flaim S. F., Morris Z. Q., Kennedy T. J. Dextran as a radioactive microsphere suspending agent: severe hypotensive effect in rat. Amer. J. Physiol 1978; 235: H587–H591